Lithium Controlled-Release and Extended-Release Tablets and Sodium phenylbutyrate
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Sodium phenylbutyrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: sodium phenylbutyrate
Brand name: Buphenyl
Synonyms: Sodium Phenylbutyrate Powder
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phenylbutyrate Powder
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phenylbutyrate Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate dibasic and sodium phosphate monobasic Rectal
- Lithium Controlled-Release and Extended-Release Tablets-Sodium phosphate p 32 Intravenous
- Lithium Controlled-Release and Extended-Release Tablets-Sodium Phosphates
- Sodium phenylbutyrate-Lithium ER
- Sodium phenylbutyrate-Lithium Oral Solution
- Sodium phenylbutyrate-Lithium Salts
- Sodium phenylbutyrate-Lithium Syrup and Oral Solution
- Sodium phenylbutyrate-Lithobid
- Sodium phenylbutyrate-Lithostat